Frailty of older patients ‘not being assessed in majority of hospitals'
Frail people are more likely to stay longer in hospital after an operation and are at greater risk of complications, researchers warned.
Experts have called for all surgical patients over 60 to be screened for frailty as standard practice to bolster recovery and slash extended stays in hospitals.
Frailty is a medical condition that is common in older people, with symptoms such as reduced muscle strength, fatigue, slower walking pace, lower activity levels, weight loss and increased vulnerability.
Clinicians can assess how frail a patient is by using the Clinical Frailty Scale (CFS), which gives a score based on factors such as walking ability and managing daily tasks.
A score of more than five indicates the patient should be referred for specialist care.
The analysis, led by the Royal College of Anaesthetists (RCoA) and the University of Nottingham and published in the British Journal of Anaesthesia, includes data from 7,129 patients.
It was collected over five days in March 2022 from across 214 NHS hospitals.
It found 71% of hospitals were not routinely screening surgical patients aged 60 and over for frailty.
The research also highlighted the risks associated with frailty.
Patients with the condition stay an average of three days longer in hospital after an operation, with severely frail people staying six days longer, and are three times more likely to have complications.
Frail patients are also four times more likely to experience delirium, a condition that causes confusion, and are also three times more likely to die in the first year after surgery.
Professor Iain Moppett, from the University of Nottingham's School of Medicine and chief investigator for the RCoA's third Sprint National Anaesthesia Project (SNAP3), said: 'Identifying frailty is straightforward and should lead to open and honest discussions with patients about what can be offered, what they want and what they can expect if they choose to have surgery.
'Good teamwork between the right specialists – surgeons, anaesthetists and geriatricians – helps to get patients living with frailty as fit and well as possible before surgery, make the right decisions and get the best care after surgery.'
RCoA president Dr Claire Shannon said: 'There is huge potential to improve patient outcomes by assessing all those over 60 for frailty as standard practice so that their care can be managed appropriately, with involvement from a geriatrician.
'With older people accounting for an increasing proportion of surgical patients, implementing effective screening for frailty is becoming ever more necessary.
'Universal adoption of frailty assessments will not only help patients recover better from surgery but also help improve efficiency by avoiding extended lengths of stay in hospital.'
An NHS spokesperson said: 'Assessing frailty is essential in helping to get older patients as fit and well as possible before, during and after surgery and the NHS elective care plan reinforces this.
'The NHS continues work to support efforts to change the way care is given to relieve the pressure on hospitals and adapt to the increasing demands of an ageing population.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
2 hours ago
- BBC News
Stafford County Hospital opens new day-case surgery hub
A new £9.8m unit for day cases has officially opened at a hospital in Hospitals of North Midlands NHS Trust (UHNM) launched the unit at County Hospital in Stafford to tackle waiting list said it would offer thousands of patients quicker access to day-case unit has a dedicated space for patients who need colorectal, upper gastroenterology, orthopaedic or ear, nose and throat surgery, freeing up more space in main theatres. It follows the recent opening of the Staffordshire Treatment Suite and North Midlands Hand Centre, also both based at County hubs are part of NHS bosses' plans to increase surgical capacity and offer quicker access to some of the most common procedures. Bosses said the day-case unit was the latest stage in turning the hospital into an "elective-hub" for patients to be seen quicker at the site most suited to their unit has almost doubled capacity from the existing 15 beds on Ward 8 to 28."By further improving and extending our surgical facilities at County Hospital, we will be able to offer thousands of patients each year with quicker access to day-case surgery, helping to improve their quality of life whilst reducing waiting lists," said UHNM chief executive Dr Simon Constable. Follow BBC Stoke & Staffordshire on BBC Sounds, Facebook, X and Instagram.
The Independent
2 hours ago
- The Independent
NHS body quietly withdraws guidance over bathroom use for trans people
The NHS Confederation has revoked guidance that advised hospitals to allow trans people to use bathrooms and changing rooms of their choice. The decision follows April's Supreme Court ruling that said the words "woman" and "sex" in the Equality Act refer to biological sex, leading to disputes over equality policies. The Equality and Human Rights Commission (EHRC) has issued interim guidance stating that trans women should not be permitted to use women's facilities, which is being legally challenged. Trans rights groups and legal experts have criticised the NHS Confederation's decision, warning of legal complexities and potential harm to trans people needing medical care. The NHS Confederation said it will update and reinstate its guidance once the EHRC updates its Code of Practice and NHS England provides further instructions.
The Sun
2 hours ago
- The Sun
The ‘golden dose' of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money
A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The weight-loss injections, which can cost hundreds of pounds a month, are designed to deliver a fixed weekly dose. But online users claim there's still a small amount of drug left after the final shot. They say it can be drawn out with a syringe for a bonus jab, dubbed the 'golden dose'. One TikTok user claimed the trick saved her a fortune. By getting five jabs from a four-dose pen, users reckon they can claw back £615 a year. The reports come after NHS England said only a small number of people will be able to get Mounjaro from their GP. It means most people will still have to pay for it privately - which can cost hundreds of pounds a month. 'The drugs are expensive but weight loss is strongly desired, so as a commodity, these drugs are hotly sought-after,' said Professor Naveed Sattar, a cardiologist and obesity expert at the University of Glasgow, said. 'It's no surprise people are going to such extraordinary lengths," she told the inews. Medics say the DIY hack is dangerous and could lead to infection, overdose or death. "People are reading these tips on online forums and being tempted to use them to save money," said Professor Penny Ward, a pharmaceutical expert at King's College London. Women taking fat jabs need 'effective contraception' - as health chiefs warn of serious harm to unborn babies "But they're risking serious side effects from overdosing by doing this - as well as the potential to develop a life-threatening infection. "The potential to develop a life-threatening infection. It's not a good idea at all," she told MailOnline. Talk of the so-called 'golden dose' is also spreading on Reddit weight-loss forums. In one thread with more than 50 comments, a user wrote: "After four pumps of your uk injection pen they tell you to throw it away. "But there is an extra dose or thereabouts in the pen you can self inject with an insulin needle." Another replied saying: "Known much more on here as the fifth dose." 2 Slimmers have also taken to TikTok to rave about the 'discovery'. In one video, a nurse demonstrates how to use a needle to extract leftover medicine from the pen. She wrote: "I do not condone or encourage anybody to take their golden dose this is just what I am doing." Huge risks Professor Penny warned that this practice can be dangerous for "several" reasons. "These injections contain a slight overfill to ensure the full recommended dose is delivered each time," she said. "But by drawing this out with a separate syringe and using it as a so-called fifth dose, you're exposing yourself to serious risk of infection.' Once the pen has been used, it's no longer sterile, meaning any leftover liquid could be contaminated with harmful bacteria. Injecting it could lead to abscesses or, in extreme cases, life-threatening sepsis. There's also the danger of taking too much. 'If you're using your own syringe, it's difficult to measure the correct amount - you may end up taking more than intended,' she warned. Overdosing on the jab can trigger nasty side effects like vomiting and diarrhoea, or in rare cases, pancreatitis - a serious and painful condition that may need hospital treatment. Around one in five cases result in serious complications, with up to 30 per cent proving fatal. The risk rises sharply with higher doses, as the drug can trigger digestive enzymes that begin attacking the pancreas itself. Symptoms include sudden, severe tummy pain, often spreading to the back, along with fever, nausea and a racing heartbeat. "The bigger the dose, the bigger the risk of pancreatitis," Professor Ward warned. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. Mounjaro - dubbed the "King Kong" of weight loss jabs - works by mimicking hormones released by the body when you're full. This makes people feel fuller for longer and therefore less hungry. It appears to be to be more potent than Wegovy - another popular weight loss jab - causing about 20 per cent weight loss after a year's use, compared with Wegovy's 15 per cent. Mounjaro's active ingredient is tirzepatide, a lab-made compound that mimics two gut hormones - GLP-1 and GIP - which help control blood sugar and appetite. This is why it was initially approved to treat diabetes type 2, which happens when people can't control their blood sugar. But in December 2024, it was also cleared for use on the NHS for weight loss in people with a BMI of over 30, or over 27 plus one weight-related condition. 'Excess solution' should be 'discarded' If you notice there is a considerable amount of medication left in your pen after the last dose, Professor Penny added, it may mean that you're not using the injection properly. "Speak to your pharmacist about your technique, or check that you definitely have the right size syringe, as this can impact the amount of medication left over," she said. A spokesperson for Lilly - the drug's manufacturer - said users should not do this, as the remaining liquid may not be a full dose. 'It is important to note that there will be a residual amount of medicine left after the fourth dose," they said. "This does not correspond to a full dose." 'Any excess solution in the pen after use should be discarded.' Dr Alison Cave, chief safety officer of the Medicines and Healthcare products Regulatory Agency, added: "Medicines are approved according to strict dosage guidelines. "Failure to adhere with these guidelines, such as tampering with pre-dosed injection pens, could harm your health or cause personal injury. "People should follow the dosing directions provided by their healthcare provider when prescribed weight-loss medicines and use as directed in the patient information leaflet." What are the other side effects of weight loss jabs? Like any medication, weight loss jabs can have side effects. Common side effects of injections such as Ozempic include: Nausea: This is the most commonly reported side effect, especially when first starting the medication. It often decreases over time as your body adjusts. Vomiting: Can occur, often in conjunction with nausea. Diarrhea: Some people experience gastrointestinal upset. Constipation: Some individuals may also experience constipation. Stomach pain or discomfort: Some people may experience abdominal pain or discomfort. Reduced appetite: This is often a desired effect for people using Ozempic for weight loss. Indigestion: Can cause a feeling of bloating or discomfort after eating. Serious side effects can also include: Pancreatitis: In rare cases, Ozempic may increase the risk of inflammation of the pancreas, known as pancreatitis, which can cause severe stomach pain, nausea, and vomiting. Kidney problems: There have been reports of kidney issues, including kidney failure, though this is uncommon. Thyroid tumors: There's a potential increased risk of thyroid cancer, although this risk is based on animal studies. It is not confirmed in humans, but people with a history of thyroid cancer should avoid Ozempic. Vision problems: Rapid changes in blood sugar levels may affect vision, and some people have reported blurry vision when taking Ozempic. Hypoglycemia (low blood sugar): Especially if used with other medications like sulfonylureas or insulin.
